Literature DB >> 19871692

RENAL EFFECTS OF HEMOGLOBIN INFUSIONS IN DOGS IN HEMORRHAGIC SHOCK.

P B Hamilton1, A Hiller, D D Van Slyke.   

Abstract

The immediate effects of treating hemorrhagic shock in dogs by replacing lost blood with 7 per cent hemoglobin solution were favorable, both on renal function and on general condition. However, subsequent transitory depression of the urea clearance for several days, shown by some of the treated animals, but not by untreated bled controls, indicates sufficient possibility of renal damage by the hemoglobin solution to prevent its recommendation at present as a blood substitute.

Entities:  

Keywords:  HEMOGLOBIN INFUSION/renal effects; SHOCK/hemorrhagic, and Hb transfusion

Mesh：

Substances：

Year:  1947        PMID： 19871692      PMCID： PMC2135756          DOI： 10.1084/jem.86.6.477

Source DB:  PubMed          Journal:  J Exp Med        ISSN： 0022-1007            Impact factor:   14.307


  3 in total

1.  CARBOHYDRATE METABOLISM IN NEPHRITIS.

Authors:  G C Linder; A Hiller; D D Van Slyke
Journal:  J Clin Invest       Date:  1925-02       Impact factor: 14.808

2.  STUDIES OF UREA EXCRETION. II: Relationship Between Urine Volume and the Rate of Urea Excretion by Normal Adults.

Authors:  E Möller; J F McIntosh; D D Van Slyke
Journal:  J Clin Invest       Date:  1928-12       Impact factor: 14.808

3.  PREPARATION OF HEMOGLOBIN SOLUTIONS FOR INTRAVENOUS INFUSION.

Authors:  P B Hamilton; L E Farr; A Hiller; D D Van Slyke
Journal:  J Exp Med       Date:  1947-11-30       Impact factor: 14.307
  3 in total
  2 in total

1.  The role of aciduria in the development of hemoglobinuric nephrosis in dehydrated rabbits.

Authors:  J J LALICH; S I SCHWARTZ
Journal:  J Exp Med       Date:  1950-07-01       Impact factor: 14.307

2.  EXPERIMENTAL STUDIES IN ACUTE RENAL FAILURE. II. FINE STRUCTURE CHANGES IN TUBULES ASSOCIATED WITH RENAL FAILURE INDUCED BY GLOBIN.

Authors:  M G MENEFEE; C B MUELLER; T B MILLER; J K MYERS; A L BELL
Journal:  J Exp Med       Date:  1964-12-01       Impact factor: 14.307
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.